T1	Intervention 19 45	gemcitabine plus docetaxel
T2	Intervention 53 80	capecitabine plus docetaxel
T3	Intervention 198 229	gemcitabine plus docetaxel (GD)
T4	Intervention 234 266	capecitabine plus docetaxel (CD)
T5	Intervention 354 384	monotherapy (GD→C or CD→G)
T6	Intervention 477 495	either gemcitabine
T7	Intervention 525 539	plus docetaxel
T8	Intervention 558 575	1 or capecitabine
T9	Intervention 609 628	1-14 plus docetaxel
T10	Intervention 674 704	received crossover monotherapy
T11	Intervention 1081 1085	More
T12	Intervention 1128 1132	than
T13	Intervention 1334 1343	comparing
T14	Intervention 1347 1350	and
T15	Intervention 1532 1539	groups.
T16	Intervention 1633 1645	neutropenia;
T17	Intervention 1723 1734	CONCLUSIONS
T18	Intervention 1738 1741	and
